share

Benzamide, 2,6-Difluoro-n-[(8-Methylimidazo[1,2-A]Pyridin-2-Yl)Methyl]- CAS NO 868970-94-9


Unit Price:

CAS No.:868970-94-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Benzamide, 2,6-Difluoro-n-[(8-Methylimidazo[1,2-A]Pyridin-2-Yl)Methyl]- is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant commercial interest for its role in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular action. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing next-generation medications.

Application

  • Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly for central nervous system (CNS) and oncology targets.
  • Active Pharmaceutical Ingredient (API) Development: Serves as a core scaffold for the research and development of new therapeutic agents.
  • Biochemical Research: Used in academic and industrial research to study enzyme inhibition and receptor-ligand interactions.
  • Preclinical Studies: Employed in the production of compounds for pharmacological and toxicological evaluation.
  • Process Chemistry: Utilized in route scouting and optimization for scalable API manufacturing processes.
  • Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting global drug discovery pipelines.

Basic Information

Product Name Benzamide, 2,6-Difluoro-n-[(8-Methylimidazo[1,2-A]Pyridin-2-Yl)Methyl]-
CAS No. 868970-94-9
Molecular Formula C16H12F2N4O
Molecular Weight 314.29 g/mol
Synonyms 2,6-Difluoro-N-[(8-methylimidazo[1,2-a]pyridin-2-yl)methyl]benzamide; 868970-94-9; N-[(8-Methylimidazo[1,2-a]pyridin-2-yl)methyl]-2,6-difluorobenzamide; 2,6-Difluoro-N-((8-methylimidazo[1,2-a]pyridin-2-yl)methyl)benzamide; Benzamide, 2,6-difluoro-N-[(8-methylimidazo[1,2-a]pyridin-2-yl)methyl]-; SCHEMBL2180627; AOB87717; BDBM50188851
EINECS Contact for details

Quality Control

Every batch of this pharmaceutical intermediate is produced under a strict quality management system to ensure consistency and traceability. Our products undergo rigorous quality testing, including advanced chromatographic and spectroscopic methods, to ensure compliance with industry and customer-specific standards. Comprehensive Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are provided with each shipment and are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The container should be kept tightly sealed in a dry environment to maintain product integrity.

Specification

Item Specification
Appearance White to off-white powder
Identification (HPLC) Conforms
Identification (IR) Conforms
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0%
Residual Solvents (GC) Meets ICH Q3C guidelines
Loss on Drying ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.